Teva Pharmaceutical Industries Ltd, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ACYCLOVIR, with a corresponding US DMF Number 16144.
Remarkably, this DMF maintains an Active status since its submission on September 24, 2002, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 24, 2014, and payment made on April 04, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II